Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Innovative Pharmaceutical Biotech ( (HK:0399) ) is now available.
Innovative Pharmaceutical Biotech Limited announced a supplemental agreement for the issuance of new shares under a general mandate, revising the subscription prices for shares to HK$0.3124 each. The revised prices represent a discount to the closing price on the agreement date and a premium to the average closing price over the preceding five days. The company expects gross proceeds of approximately HK$28.116 million, which will be used for general working capital, potentially enhancing its operational capabilities and market position.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of medical products and technologies.
Average Trading Volume: 8,277,125
Technical Sentiment Signal: Buy
Current Market Cap: HK$516.8M
See more data about 0399 stock on TipRanks’ Stock Analysis page.